blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1670448

EP1670448 - HCV INHIBITING SULFONAMIDES [Right-click to bookmark this link]
Former [2006/25]HCV INHIBITIING SULFONAMIDES
[2007/18]
StatusNo opposition filed within time limit
Status updated on  26.09.2008
Database last updated on 03.10.2024
Most recent event   Tooltip23.07.2010Lapse of the patent in a contracting state
New state(s): HU		published on 25.08.2010  [2010/34]
Applicant(s)For all designated states
Tibotec Pharmaceuticals Ltd.
Eastgate Village Eastgate Little Island
Co Cork / IE
[2006/46]
Former [2006/25]For all designated states
Tibotec Pharmaceuticals Ltd.
Little Island
Co Cork / IE
Inventor(s)01 / SIMMEN, Kenneth Alan
Boterbloemenlaan 35
B-3080 Tervuren / BE
02 / VAN ACKER, Koenraad Lodewijk August
Uilenberg 30
B-9140 Temse / BE
03 / WIGERINCK, Piet Tom Bert Paul
Kardinaal Cardijnstraat 29
B-2840 Terhagen / BE
04 / SURLERAUX, Dominique Louis Nestor Ghislain
rue de la scaillée, 13
B-1440 Braine-le-château / BE
05 / DAMS, Géry Karel Julia
Nieuwe Erven 11
B-3583 Paal-Beringen / BE
06 / QUIRYNEN, Ludo Maria Marcel
Katelijnestraat 19F
B-2320 Hoogstraten / BE
07 / HERTOGS, Kurt
Mechelbaan 522, bus 5
B-2580 Putte / BE
08 / PAUWELS, Rudi Wilfried Jan
Chemin de Layaz 3
CH-1806 Saint-Légier La Chiésaz / CH
 [2006/25]
Representative(s)Daelemans, Frank F.R.
Tibotec-Virco Comm. VA J&J Patent Law Department Generaal De Wittelaan L 11B 3
2800 Mechelen / BE
[N/P]
Former [2006/25]Daelemans, Frank F.R.
Tibotec-Virco Comm. VA, Generaal De Wittelaan L11B3
2800 Mechelen / BE
Application number, filing date04766871.030.09.2004
[2006/25]
WO2004EP52388
Priority number, dateEP2003010362930.09.2003         Original published format: EP 03103629
US20030507535P01.10.2003         Original published format: US 507535 P
[2006/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005030194
Date:07.04.2005
Language:EN
[2005/14]
Type: A1 Application with search report 
No.:EP1670448
Date:21.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2005 takes the place of the publication of the European patent application.
[2006/25]
Type: B1 Patent specification 
No.:EP1670448
Date:21.11.2007
Language:EN
[2007/47]
Search report(s)International search report - published on:EP07.04.2005
ClassificationIPC:A61K31/18, A61K31/426, A61K31/421, A61P31/14
[2006/25]
CPC:
A61K45/06 (EP,US); A61K31/18 (EP,US); A61K31/421 (EP,US);
A61K31/426 (EP,US); A61P1/16 (EP); A61P31/12 (EP);
A61P31/14 (EP); A61P31/18 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/18, A61K2300/00 (EP,US);
A61K31/421, A61K2300/00 (US,EP);
A61K31/426, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/25]
Extension statesAL02.05.2006
HR02.05.2006
LT02.05.2006
LV02.05.2006
MK02.05.2006
TitleGerman:HCV-HEMMENDE SULFONAMIDE[2006/25]
English:HCV INHIBITING SULFONAMIDES[2007/18]
French:SULFONAMIDES INHIBANT LE HCV[2006/25]
Former [2006/25]HCV INHIBITIING SULFONAMIDES
Entry into regional phase02.05.2006National basic fee paid 
02.05.2006Designation fee(s) paid 
02.05.2006Examination fee paid 
Examination procedure02.05.2006Examination requested  [2006/25]
29.05.2007Communication of intention to grant the patent
08.10.2007Fee for grant paid
08.10.2007Fee for publishing/printing paid
Opposition(s)22.08.2008No opposition filed within time limit [2008/44]
Fees paidRenewal fee
02.10.2006Renewal fee patent year 03
01.10.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY21.11.2007
CZ21.11.2007
DK21.11.2007
EE21.11.2007
FI21.11.2007
RO21.11.2007
SI21.11.2007
SK21.11.2007
BG21.02.2008
GR22.02.2008
HU22.05.2008
[2010/34]
Former [2009/35]CY21.11.2007
CZ21.11.2007
DK21.11.2007
EE21.11.2007
FI21.11.2007
RO21.11.2007
SI21.11.2007
SK21.11.2007
BG21.02.2008
GR22.02.2008
Former [2009/22]CZ21.11.2007
DK21.11.2007
EE21.11.2007
FI21.11.2007
RO21.11.2007
SI21.11.2007
SK21.11.2007
BG21.02.2008
GR22.02.2008
Former [2009/13]CZ21.11.2007
DK21.11.2007
FI21.11.2007
RO21.11.2007
SI21.11.2007
SK21.11.2007
BG21.02.2008
GR22.02.2008
Former [2008/39]CZ21.11.2007
DK21.11.2007
FI21.11.2007
RO21.11.2007
SI21.11.2007
SK21.11.2007
BG21.02.2008
Former [2008/35]CZ21.11.2007
DK21.11.2007
FI21.11.2007
SI21.11.2007
BG21.02.2008
Former [2008/26]FI21.11.2007
SI21.11.2007
BG21.02.2008
Former [2008/25]FI21.11.2007
BG21.02.2008
Cited inInternational search[A]US6514953  (ARMITAGE IAN GORDON [GB], et al) [A] 1-14 * column 5, paragraph 2 * * claims *;
 [A]WO03064416  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-14 * claims *;
 [A]US2003050229  (SOMMADOSSI JEAN-PIERRE [US], et al) [A] 1-14 * the whole document *;
 [ADY]WO9506030  (SEARLE & CO [US], et al) [AD] 1-14 * examples 17A,17B,18C,19B,20C,21C * * page 240 - page 244 * [Y] 15,16;
 [YD]WO03053435  (TIBOTEC PHARM LTD [IE], et al) [YD] 15,16 * page 31 *;
 [A]  - JOHANSSON ANJA ET AL, "Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): A comparative study of different C-terminals.", BIOORGANIC AND MEDICINAL CHEMISTRY, (20030612), vol. 11, no. 12, ISSN 0968-0896 (ISSN print), pages 2551 - 2568, XP002272318 [A] 1-14 * compounds 45a,45b,46a,46b *

DOI:   http://dx.doi.org/10.1016/S0968-0896(03)00179-2
 [Y]  - PALMON RON ET AL, "Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (20020401), Database accession no. NLM11917237, XP002319202 [Y] 15,16 * abstract *
    [ ] - JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999) 1 APR 2002, (20020401), vol. 29, no. 4, ISSN 1525-4135, pages 340 - 345
 [PY]  - ROCKSTROH JÜRGEN KURT, "Management of hepatitis B and C in HIV co-infected patients.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200309), Database accession no. NLM14562859, XP002319203 [PY] 15,16 * abstract *
    [ ] - JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999) SEP 2003, (200309), vol. 34 Suppl 1, ISSN 1525-4135, pages S59 - S65
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.